In a few weeks, researchers expect to understand more about how well vaccines fare when they do battle with the new variant. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) said there will be a lot of unfiltered information coming out over the next couple of weeks but that he thinks the scientific community has engaged very quickly and is hopeful a scientific consensus will emerge.
In a pair of papers and a guest editorial published in Dimensions of Critical Care Nursing, a team of nurse-scientists at BIDMC shared their experiences nearly doubling the hospital's intensive care unit capacity; identifying, training and redeploying staff; and developing and implementing a proning team to manage patients with acute respiratory distress syndrome during the first COVID-19 surge. Sharon O'Donoghue, DNP, RN (Nursing, BIDMC) discussed how nurses at BIDMC were preparing for the projected influx of highly infectious, critically ill patients – and how they planned and strategized for these patients’ arrival.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) and members of his lab spoke with the Boston Globe about the first minutes and hours after they learned about the new Omicron variant on the Thanksgiving holiday. The researchers are part of a global effort to understand the fast-spreading variant.
The Omicron variant of the coronavirus has arrived in the United States, the US Centers for Disease Control and Prevention said Wednesday. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) told the Boston Globe last week that the variant has features that warrant concern, but there’s so much unknown that it’s not a reason to panic as of today.
ABC News – November 22, 2021 Experts say it’s important to understand that protection from COVID-19 doesn’t kick in right...
WBUR – November 23, 2021 This WBUR piece highlights a BIDMC patient’s long COVID journey and how the hospital’s Critical...
Harvard Health Publishing – November 22, 2021 Harvard Health Publishing faculty contributors, including Suzanne Salamon, MD (Geriatric Medicine, BIDMC), answered...
Harvard Medical School – November 19, 2021 In a recent phase 2b/3 clinical trial, a third mRNA vaccine against COVID-19 — known as CVnCoV and...
Bloomberg – November 17, 2021 The researchers studying the mid-summer COVID-19 outbreak in Provincetown are gaining important insights into the...
